16:33 IST
BSE
Annual Report
Lasa Supergenerics Annual Report
Lasa Supergenerics Ltd has submitted its 11th Annual Report for the financial year 2025-26. The Annual General Meeting is scheduled for September 30, 2026.
Lasa Supergenerics Ltd
- Share price
- ₹5.89
- Market cap
- ₹29.51 Cr
- Revenue (annual)
- ₹25.14 Cr
- Net profit (annual)
- ₹-34.09 Cr
- P/E (TTM)
- -1.8×Sector 50.4×
- Promoter holding
- 53.65%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements
17:30 IST
BSE
Annual General Meeting
Lasa Supergenerics Annual General Meeting
Lasa Supergenerics Limited has issued a notice for its Annual General Meeting to be held on September 30, 2026, featuring seven agenda items.
17:09 IST
BSE
Board Meeting Outcome
Lasa Supergenerics Board Meeting Outcome
Lasa Supergenerics announced the outcome of its board meeting held on September 09, 2026. The board approved the notice for the 11th Annual General Meeting.
18:23 IST
BSE
Financial Results
Lasa Supergenerics Q1 FY27 Results: Net Loss of ₹3.6 Cr, Loss Narrows
Lasa Supergenerics Ltd reported revenue from operations of ₹1.2 Cr (-94.0% YoY) and a net loss of ₹3.6 Cr for Q1 FY27.
- Key figure
- Net loss ₹3.6 Cr
18:19 IST
BSE
Financial Results
Lasa Supergenerics Q4 FY26 Results: Net Loss of ₹4.2 Cr, Loss Narrows
Lasa Supergenerics Ltd reported revenue from operations of -₹0.1 Cr and a net loss of ₹4.2 Cr for Q4 FY26.
- Key figure
- Net loss ₹4.2 Cr